Breast Cancer Res. 2008;10 Suppl 4:S4. Epub 2008 Dec 18.

The utility of conventional and molecular pathology in managing breast cancer.

Department of Pathology and Immunology, Washington University School of Medicine, St, Louis, MO 63110, USA. dcallred@path.wustl.edu

PMID: 19128442 [PubMed - indexed for MEDLINE]

PMCID: PMC2614856

MeSH Terms

The use of microarray technology in the management of breast cancer.
Clin Adv Hematol Oncol. 2007 Mar; 5(3):193-4, 197.

[Clin Adv Hematol Oncol. 2007]
Gene-expression profiling in breast cancer.
Lancet. 2005 Feb 19-25; 365(9460):634-5.

[Lancet. 2005]
Predicting the future of breast cancer.
Nat Med. 2003 Jan; 9(1):16-8.

[Nat Med. 2003]
ReviewGene-expression signatures in breast cancer.
N Engl J Med. 2009 Feb 19; 360(8):790-800.

[N Engl J Med. 2009]
ReviewGenetic profiling of breast cancer: from molecular portraits to clinical utility.
Int J Biol Markers. 2003 Jan-Mar; 18(1):54-6.

[Int J Biol Markers. 2003]
» See reviews... | » See all...

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC

Your browsing activity is empty.

Activity recording is turned off.